• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Study: Visual decreases within a day after uneventful phacoemulsification surgery

Article

With the safety and efficacy of phacoemulsification having increased to the point that it is no longer standard practice to examine patients the day after surgery, clinicians may be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.

Visual decreases are rare after phacoemulsification, but they can occur within 1 day postoperatively.

Visual decreases are rare after phacoemulsification, but they can occur within 1 day postoperatively.

Visual decreases are rare after phacoemulsification, but they can occur within 1 day postoperatively,1 according to professors Harry Rosen and Stephen Vernon.

Rosen is from the Charing Cross Hospital, Imperial College Healthcare National Health Service Trust, London, and Vernon is affiliated with the Ophthalmic Service, The Park Hospital, Nottingham, UK.

The safety and efficacy of phacoemulsification have increased to the point that it is no longer standard practice to examine patients the day after surgery, they pointed out. However, because of the rarity of visual decreases, the investigators stated that “clinicians are therefore likely to be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.”

In light of this, Rosen and Vernon conducted a literature review to pinpoint the cause of visual decreases early postoperatively. They found various optical, anterior segment, lens-related and posterior segment causes, such as a shallow anterior chamber, lens dislocation, refractive surprise of 1 diopter or more, corneal abrasion, corneal edema, corneal endothelial decompensation, toxic anterior segment syndrome, hyphema, endophthalmitis, opacification, vitreous hemorrhage, and macular holes, among other.

However, paracentral acute middle maculopathy (PAMM), according to the authors, is unique in that it lacks positive findings during clinical examinations, and should be considered as a diagnosis of exclusion.

The investigators described that postoperatively, PAMM is characterized by a dense central scotoma presenting on the first postoperative day, often with no clinical signs on the examination.

“The diagnosis is defined by a hyperreflective band on optical coherence tomography confined to the retinal inner nuclear layer (INL), with subsequent thinning and loss of the negative signal layer of the INL,” the investigators noted.

PAMM is believed to result from transient ischemia of the deep and intermediate retinal capillary plexus, causing irreversible INL necrosis.

“Clinicians are becoming increasingly unfamiliar with the causes of visual loss 1 day following cataract surgery,” Rosen and Vernon concluded. “We reviewed the differential causes and their presentations as an aid to clinicians reviewing such patients in emergency care. PAMM is a unique condition in its paucity of positive clinical examination findings, and should be considered as a diagnosis of exclusion, with the appropriate radiological evidence.”

Reference

1. Rosen H, Vernon S. Unexpected poor vision within 24 h of uneventful phacoemulsification surgery—a review. J Clin Med. 2023;12: 48; https://doi.org/10.3390/jcm12010048

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.